October 2017—Grifols and Beckman Coulter have entered into an exclusive, long-term agreement for the global distribution of Grifols’ hemostasis instruments, reagents, and consumables. The companies anticipate first commercializing systems under this agreement in Europe in early 2018.
Read More »Home >> Tag Archives: Grifols
FDA-cleared automated IFA system, 9/16
September 2016—Aesku Group has received FDA 510(k) clearance for its Helios Automated IFA System with Aeskuslides ANA HEp-2-Gamma Assay.
Read More »Novartis to sell its blood transfusion diagnostics unit to Grifols, 12/13
December 2013—Novartis announced a definitive agreement to sell its blood transfusion diagnostics unit to Grifols for $1.675 billion. The transaction is expected to be completed in the first half of 2014.
Read More »